T-cell Immunoglobulin and Mucin-Domain-Containing Molecule-3 (TIM3) is present on T-helper type 1 lymphocytes and other immune cells including dendritic cells and natural killer cells. TIM3 is overexpressed in CD4+ tumor-infiltrating lymphocytes, including those with non-small cell lung cancer associated with poor prognoses. TIM3 has recently emerged as a potential target for cancer immunotherapy.

SKU: N/A Category:
Image Variation SKU Price Quantity Add To Cart
TIM3-IHC003-Kidney-40X 0.1ml IHC003-100 671.00
Add to cart
TIM3-IHC003-Kidney-40X 1ml IHC003-1 3,484.00
Add to cart
TIM3-IHC003-Kidney-40X Positive Control IHC003-PC 1,323.00
Add to cart


CE-IVD certified and supplied as a concentrate.


Clone IHC003
Source Mouse Monoclonal
Positive Control Tonsil
Dilution Range 1:100 – 1:200


  1. Monney L, et al. Nature. 2002; 415:536-41.
  2. Sánchez-Fueyo A, et al. Nat Immunol. 2003; 4:1093-101.
  3. Anderson AC. Cancer Immun Res. 2014; 2:393–8.
  4. Gao X, et al. PLoS One. 2012; 7:e30676.

Additional information


0.1ml, 1ml, Positive Control


Instructions for Use

Safety Data Sheet

Price Quote